复星医药
(600196)
| 流通市值:441.07亿 | | | 总市值:555.98亿 |
| 流通股本:21.18亿 | | | 总股本:26.70亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 30,463,029,335.95 | 20,441,970,386 | 10,073,223,477.03 | 41,661,612,748.15 |
| 营业总成本 | 29,215,995,428.44 | 19,682,627,988.3 | 9,532,295,160.5 | 40,087,325,053.49 |
| 其他经营收益 | | | | |
| 营业利润 | 3,929,023,074.49 | 2,615,941,075.38 | 1,375,376,200.03 | 5,228,351,339.59 |
| 利润总额 | 3,878,773,025.46 | 2,586,571,906.93 | 1,357,544,436.17 | 5,111,983,263.87 |
| 净利润 | 3,247,116,277.12 | 2,148,928,430.32 | 1,079,627,854.14 | 4,247,929,628.38 |
| 每股收益 | | | | |
| 其他综合收益 | -1,264,587,213.04 | -913,684,904.03 | -616,755,016.63 | -675,759,872.93 |
| 综合收益总额 | 1,982,529,064.08 | 1,235,243,526.29 | 462,872,837.51 | 3,572,169,755.45 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 34,543,238,143.77 | 34,799,347,678.29 | 33,964,684,348.73 | 33,820,671,330.27 |
| 非流动资产: | | | | |
| 非流动资产合计 | 92,243,498,806.33 | 90,628,555,416.56 | 89,001,703,917.37 | 86,233,297,595.78 |
| 资产总计 | 126,786,736,950.1 | 125,427,903,094.85 | 122,966,388,266.1 | 120,053,968,926.05 |
| 流动负债: | | | | |
| 流动负债合计 | 35,303,449,620.77 | 38,595,926,544.58 | 36,580,714,242.42 | 36,424,316,078.84 |
| 非流动负债: | | | | |
| 非流动负债合计 | 25,409,418,404.66 | 23,430,053,586.74 | 22,716,324,968.36 | 21,789,302,995.87 |
| 负债合计 | 60,712,868,025.43 | 62,025,980,131.32 | 59,297,039,210.78 | 58,213,619,074.71 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 50,304,754,985.57 | 48,731,193,493.03 | 49,146,744,750.46 | 48,741,507,004.7 |
| 股东权益合计 | 66,073,868,924.67 | 63,401,922,963.53 | 63,669,349,055.32 | 61,840,349,851.34 |
| 负债和股东权益合计 | 126,786,736,950.1 | 125,427,903,094.85 | 122,966,388,266.1 | 120,053,968,926.05 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 32,657,880,589.64 | 21,969,649,537.43 | 11,104,892,656.89 | 43,315,418,661.34 |
| 经营活动现金流出小计 | 29,230,778,460.8 | 19,545,697,122.75 | 9,956,294,869.07 | 38,102,191,782.99 |
| 经营活动产生的现金流量净额 | 3,427,102,128.84 | 2,423,952,414.68 | 1,148,597,787.82 | 5,213,226,878.35 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,531,136,266.11 | 907,292,950.29 | 590,290,272.15 | 3,722,258,666.04 |
| 投资活动现金流出小计 | 7,090,183,052.55 | 5,335,391,260.84 | 2,319,574,775.55 | 5,868,024,954.77 |
| 投资活动产生的现金流量净额 | -5,559,046,786.44 | -4,428,098,310.55 | -1,729,284,503.4 | -2,145,766,288.73 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 27,056,040,893.23 | 13,929,238,711.21 | 7,953,358,102.47 | 37,334,019,380.15 |
| 筹资活动现金流出小计 | 24,072,693,580.58 | 11,253,234,699.24 | 6,675,162,903.95 | 40,578,108,887.3 |
| 筹资活动产生的现金流量净额 | 2,983,347,312.65 | 2,676,004,011.97 | 1,278,195,198.52 | -3,244,089,507.15 |
| 汇率变动对现金及现金等价物的影响 | -319,036,554.6 | -222,600,992.35 | -158,570,564.25 | -176,810,748.88 |
| 现金及现金等价物净增加额 | 532,366,100.45 | 449,257,123.75 | 538,937,918.69 | -353,439,666.41 |
| 期末现金及现金等价物余额 | 9,570,376,221.15 | 9,487,267,244.45 | 9,576,948,039.39 | 9,038,010,120.7 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 449,257,123.75 | - | -353,439,666.41 |
最新报告期:2026-11-12| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 天风证券 | 杨松,刘一伯 | 1.30 | 1.55 | 1.87 | 2026-11-12 |
| 中国银河 | 程培,宋丽莹 | 1.36 | 1.56 | 1.73 | 2026-10-28 |
| 浙商证券 | 郭双喜 | 1.42 | 1.72 | 1.92 | 2026-09-24 |
| 中国银河 | 程培,宋丽莹 | 1.36 | 1.56 | 1.73 | 2026-08-28 |